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a b s t r a c t
The discovery of new or divergent viruses using metagenomics and high-throughput sequencing has
become more commonplace. The preparation of a sample is known to have an effect on the represen-
tation of virus sequences within the metagenomic dataset yet comparatively little attention has been
given to this. Physical enrichment techniques are often applied to samples to increase the number of viral
sequences and therefore enhance theprobability of detection.With the exceptionof virus ecology studies,
there is a paucity of information available to researchers on the type of sample preparation required for a
viralmetagenomic study that seeks to identify anaetiological virus in ananimal orhumandiagnostic sam-
ple.A reviewofpublishedvirusdiscovery studies revealed themost commonlyusedenrichmentmethods,
that were usually quick and simple to implement, namely low-speed centrifugation, ﬁltration, nuclease-
treatment (or combinations of these) which have been routinely used but often without justiﬁcation.
Thesewere applied to a simple andwell-characterised artiﬁcial sample composed of bacterial and human
cells, as well as DNA (adenovirus) and RNA viruses (inﬂuenza A and human enterovirus), being either
non-enveloped capsid or enveloped viruses. The effect of the enrichment method was assessed by both
quantitative real-timePCRandmetagenomic analysis that incorporated anampliﬁcation step. Reductions
in the absolute quantities of bacteria and human cells were observed for each method as determined
by qPCR, but the relative abundance of viral sequences in the metagenomic dataset remained largely
unchanged. A 3-step method of centrifugation, ﬁltration and nuclease-treatment showed the greatest
increase in the proportion of viral sequences. This study provides a starting point for the selection of a
puriﬁcation method in future virus discovery studies, and highlights the need for more data to validate
the effect of enrichment methods on different sample types, ampliﬁcation, bioinformatics approaches
and sequencing platforms. This study also highlights the potential risks that may attend selection of a
virus enrichment method without any consideration for the sample type being investigated.
2013©
. IntroductionSince theproliferationofhigh-throughput sequencing technolo-
ies, the search for viruses has entered a new era (Lipkin, 2010,
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2013). These technologies are capable of producing millions of
sequence readswithout apriori knowledgeof the sample. Sequence
data generated from a sample is compared to known sequence
databases in order to identify viruses. Previously, virus metage-
nomicswas accomplished by cloning and sanger-based sequencing
of randomly ampliﬁed nucleic acid (Breitbart et al., 2003; Djikeng
et al., 2008). Despite the small amount of sequence data produced,
it was still possible to detect viruses due to either high concen-
trations, or some process of prior enrichment being applied that
removes host cells and exogenous nucleic acid.
The relative abundance of a virus (or viral nucleic acid) in a
sample, compared to that of other organisms such as bacteria or
Open access under CC BY-NC-ND license.host cells (or their genomes), is a critical factor for the discovery
of viruses when using metagenomics. A higher proportion of viral
sequence increases the probability that (1) viral sequences will be
represented in a metagenomic dataset and (2) larger contigs can be
 license.
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ssembled, increasing the likelihood of a match in the database. It
s has been shown that without some type of physical enrichment
ethod, viruses may not be present in high enough concentrations
o be detected (Daly et al., 2011). This problem is somewhat over-
ome as high-throughput sequencing technologies advance in both
ead length and sequencing depth. Nevertheless, gains in sensitiv-
ty are still possible by the application of a physical enrichment
rocess for viruses, and may also avoid the cost of generating and
nalysing additional data.
In the ﬁeld of viral ecology there have already been signiﬁ-
ant advances in the validation of physical enrichment methods for
iruses (Duhaime and Sullivan, 2012; John et al., 2011), such as the
ethods used to concentrate and purify viruses from seawater for
irus discovery by metagenomics (Hurwitz et al., 2013). However,
nly a few methodological studies have been applied to evaluate
he efﬁciency of viral enrichment methods in metagenomics that
eek to diagnose animal or human disease. A study on human liver
issue compared enrichment techniques of freeze–thaw, centrifu-
ationandnuclease-treatment for thedetectionofHepatitis CVirus
sing both Roche 454 and Illumina high-throughput sequencing
latforms (Daly et al., 2011). The abundance of viral sequences in
ach treatment group was compared to results obtained by quanti-
ative real-time PCR detection of transcripts, and the effect of each
reatment method on viral genome coverage was also determined.
uch studies show that physical enrichment methods do increase
he sensitivity of detection for viruses in metagenomics.
For new researchers looking to perform work on human or ani-
al samples for the purposes of detecting or diagnosing new or
nexpected viruses, it can be difﬁcult to ascertain which virus
nrichment method may be applicable to a given sample type.
ethods described for viral ecology studies are unlikely to be appli-
able. A review was undertaken of 24 published metagenomic
tudies that sought to describe viruses present in human or ani-
al samples (excluding virus ecology studies) and provide details
n the enrichment methods used (Table 1 ). Most of these studies
ncorporate the use of low-speed centrifugation and/or ﬁltration to
emove host cells or other micro-organisms, with a ﬁnal nuclease-
reatment step, where DNAse or RNAse will destroy exogenous
ucleic acid but is not thought to affect nucleic acid protected by
he viral capsid or envelope. Ultracentrifugation also features as a
ommon method for the concentration of viruses from samples.
The application of virus discoverymethods usingmetagenomics
as been considered for routine use in diagnostic and reference lab-
ratories to aid in the diagnosis of human (Svraka et al., 2010) and
nimal disease (Belak et al., 2013). The application of these tech-
iques in a clinical setting will require that any virus enrichment
ethods are simple to perform, fast, robust, effective, standard-
sed and do not require signiﬁcant capital expenditure. It is noted
hat the vast majority of the published studies in Table 1 apply the
imple enrichment techniques without any a priori justiﬁcation for
he selection of the technique. This study sought to examine the
apid and simple enrichment techniques for viruses that appear
o be in routine use in the literature for diagnosing animal and
uman diseases, but for which the effects on metagenomic data
ave not been studied. Thiswas achieved by examining the effect of
hese enrichmentmethods on the relative abundance of viruses in a
etagenomicdatasetderived fromasimpleandwell-characterised
rtiﬁcial sample.
. Materials and methods
.1. Generation of an artiﬁcial sample containing bacteria,
uman cells and viruses
Human enterovirus 71 was cultured in human rhabdomyosar-
oma cell line in Hanks MEM (Life Technologies, Carlsbad, CA, USA)Methods 195 (2014) 194–204 195
supplemented with 5% foetal bovine serum (Thermoﬁsher Scien-
tiﬁc, Waltham, MA, USA). Human adenovirus 5 was also cultured in
the human rhabdomyosarcoma cell line. Inﬂuenza A(H1N1)pdm09
was cultured in MDCK-SIAT1 cells (canine) in R-Mix (Diagnostic
Hybrids, Athens, OH, USA). All virus cultures were composed of
cell culture supernatant and monolayer present after freeze–thaw.
Escherichia coli O157 was cultured in Brain Heart Infusion broth
(BHI) and incubated at 37 ◦C overnight. Human A549 cells were
cultured in DMEM (Life Technologies, Carlsbad, CA, USA) sup-
plemented with 5% foetal bovine serum (Thermoﬁsher Scientiﬁc,
Waltham, MA, USA).
An artiﬁcial sample was formulated to consist of known
amounts of E. coli O157, A549 human epithelial lung carcinoma
cells (ATCC CCL-185), human enterovirus 71, human adenovirus 5
and inﬂuenza A(H1N1)pdm09. Aliquots of the ﬁnal dilution were
subjected to three freeze–thaw cycles and were frozen and stored
at −80 ◦C.
2.2. Virus enrichment methods
Based upon a review of enrichment methods presented in
Table 1, ﬁve combinations of three simple methods of enrichment
were selected and performed on 1mL aliquots of the artiﬁcial sam-
ple as follows; low-speed centrifugation in a microfuge at 6000× g
for 10min at 4 ◦C, sterile syringe ﬁltration at 0.45m, nuclease
treatment using 0.1UL−1 Turbo DNAse (Life Technologies, Carls-
bad, CA, USA), 0.1UL−1 RNAseOne (Promega, Fitchburg,WI, USA)
and 1X DNAse buffer (Life Technologies, Carlsbad, CA, USA) and
incubation at 37 ◦C for 90min, or combinations of these being a
2-step method (centrifugation followed by ﬁltration), or 3-step
(centrifugation, ﬁltration then nuclease-treatment). Independent
duplicates for each treatment were performed and used in all sub-
sequent experiments.
2.3. Nucleic acid preparation
The extraction of RNA was achieved using the iPrep PureLink
VirusKit (Life Technologies, Carlsbad, CA,USA),where 400L of the
artiﬁcial samplewas extracted andeluted into100L ofmolecular-
biology grade water.
2.4. Quantitative real-time PCR assays
All real-time quantitative PCR assays (qPCR) were performed on
a Stratagene Mx3000P Real-Time PCR System (Agilent Technolo-
gies, Santa Clara, CA, USA). qPCR on extracted RNA was used to
quantify A549 human cells, inﬂuenza, adenovirus, E. coli O157 and
enterovirus present in the artiﬁcial sample.
The human RNase P (RNP) gene was used as a target for the
detection of human A549 cellular RNA. The nucleoprotein gene tar-
get was used for the detection of inﬂuenza A(H1N1)pdm09 RNA.
Both assays were performed using the AgPath One Step RT-PCR
Kit reagents (Life Technologies, Carlsbad, CA, USA) and the primers
and probes for these assays have been previously described (WHO,
2011). Each 25L reaction contained 5L of nucleic acid, 12.5L
of RT-PCR Buffer, 1L of 25X RT-PCR Enzyme Mix, 0.1M probe
and 0.4M primers. Following an initial 30min reverse transcrip-
tion step at 50 ◦C and 10min denaturation step at 95 ◦C, a 2-step
cycling procedure of denaturation at 95 ◦C for 15 s with annealing
and extension at 55 ◦C for 30 s over 40 cycles was used.
Adenovirus DNA was detected using a previously published
assay (Brittain-Long et al., 2008) and the AgPath One Step RT-PCR
Kit (Life Technologies, Carlsbad, CA, USA). Each 25L reaction con-
tained 5L of DNA, 12.5L of RT-PCR Buffer, 1L of 25X RT-PCR
Enzyme Mix, 0.4M probe and 0.5M primers. After an initial
10min reverse transcription step at 45 ◦C and 10min denaturation
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Table 1
Virus enrichment process prior to sequencing in metagenomic studies on human and animal samples.
Paper title Author Year Journal Aim of study Sample Step 1 Step 2 Step 3 Step 4 Step 5 Step 6 Step 7 Ampliﬁcation Sequencing
A virus discovery
method
incorporating
DNase
treatment and
its application to
the
identiﬁcation of
two bovine
parvovirus
species
Allander
et al.
2001 PNAS Development
of a method
for discovery
of unknown
viruses and
elimination of
contaminat-
ing host DNA.
Allowed the
discovery of
novel bovine
parvoviruses.
Serum – – – – – Sequence-
Independent
Ampliﬁcation
Cloning and
sanger-
method
Metagenomic
analyses of an
uncultured viral
community
from human
faeces
Breitbart
et al.
2003 Journal of
Bacteriology
Metagenomic
analyses of an
uncultured
viral
community
from human
faeces
Faecal
suspension
– – – – Sequence-
independent
Ampliﬁcation
Cloning and
sanger-
method
Identiﬁcation of a
new human
coronavirus
van der
Hoek
et al.
2004 Nature
Medicine
Identiﬁcation
of a new
human
coronavirus
Suspension of
LLC-MK2 cells
– – – – – VIDISCA cDNA-AFLP,
cloning and
sanger-
method
Viral genome
sequencing by
random priming
methods
Djikeng
et al.
2008 BMC
Genomics
Development
of a method
for rapid
sequencing of
whole
genomes
from new
viruses
Bacterial
growth
media,
plasma, cell
culture
supernatant,
faecal
suspension
– – – Sequence-
Independent
Ampliﬁcation
Cloning and
sanger-
method
A highly divergent
Picornavirus in a
marine mammal
Kapoor
et al.
2008 Journal of
Virology
Unidentiﬁed
virus cultured
from a seal
Supernatant
from infected
Vero cell
culture
– – – Sequence-
Independent
Ampliﬁcation
Cloning and
sanger-
method
Rapid
identiﬁcation of
known and new
RNA viruses
from animal
tissues
Victoria
et al.
2008 PLOS
Pathogens
Unidentiﬁed
viruses
cultured in
suckling
mouse brains
Brain tissue
homogenate
from mice
– – – Sequence-
Independent
Ampliﬁcation
Cloning and
sanger-
method
Discovery of a
novel
single-stranded
DNA virus from
a Sea Turtle
Fibropapilloma
by using viral
metagenomics
Ng et al. 2009 Journal of
Virology
To investigate
and puriﬁy
the viruses
associated
with sea
turtle ﬁbropa-
pillomatosis
(FP)
External
ﬁbropapil-
loma
homogenate
– – Sequence-
Independent
Ampliﬁcation
Cloning and
sanger-
method
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Laboratory
procedures to
generate viral
metagenomes
Thurber
et al.
2009 Nature
Protocols
Development
of laboratory
procedure for
making viral
metagenomes
Various (i.e.
soil, animal
tissues,
clinical
samples)
– – – As required.
Genomiphi or
Transplex
High-
throughput
sequencing
Identiﬁcation and
characterisation
of deer
astroviruses
Smits
et al.
2010 Journal of
General
Virology
Detection of
novel
astroviruses
in deer using
a
metagenomic
approach
Faecal
suspension
– – – – Sequence-
Independent
Ampliﬁcation
Cloning and
sanger-
method
Metagenomic
sequencing for
virus
identiﬁcation in
a public-health
setting
Svraka
et al.
2010 Journal of
General
Virology
Unidentiﬁed
viruses
cultured in
in vitro cell
lines
Cell culture
suspension
– – – – Whole Trans-
criptome
Ampliﬁcation
Kit (Qiagen)
or GenomiPhi
V2 (GE
Healthcare)
Cloning and
sanger-
method
Human
Picobirnaviruses
identiﬁed by
molecular
screening of
diarrhoea
samples
Van
Leeuwen
et al.
2010 Journal of
Clinical
Microbiology
Viral
metagenomic
survey of
human
diarrhoea of
unknown
origin
Faecal
suspension
– – – – Sequence-
Independent
Ampliﬁcation
Cloning and
sanger-
method
A viral discovery
methodology for
clinical biopsy
samples utilising
massively
parallel next
generation
sequencing
Daly
et al.
2011 PLOS ONE Development
of a method
for discovery
of new
viruses from
clinical biopsy
samples
Liver tissue
homogenate
from human
and canine
– – – – Sequence-
Independent
Ampliﬁcation
454
sequencing
(Roche) and
GAII
sequencing
(Illumina)
Identiﬁcation and
molecular
characterisation
of a new
nonsegmented
double-stranded
RNA virus
isolated from
Culex
mosquitoes in
Japan
Isawa
et al.
2011 Virus
Research
Identiﬁcation
of 2 infectious
agents from
the
mosquitoes
Culex pipiens
pallens and
Culex inatomii
Mosquito
homogenate
– – – Sequence-
Independent
Ampliﬁcation
(Single Primer
Ampliﬁcation
Technique –
SPAT)
Sanger-
method
Diversity and
abundance of
single-stranded
DNA viruses in
human faeces
Kim et al. 2011 Applied and
Environmen-
tal
Microbiology
Investigation
of single-
stranded DNA
viruses in
human faeces
Faecal
suspension
– – – GenomiPhi
V2 (GE
Healthcare)
454FLX
sequencing
(Roche)
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Table 1 (Continued)
Paper title Author Year Journal Aim of study Sample Step 1 Step 2 Step 3 Step 4 Step 5 Step 6 Step 7 Ampliﬁcation Sequencing
Novel DNA virus
isolated from
samples
showing
endothelial cell
necrosis in the
Japanese eel,
Anguilla japonica
Mizutani
et al.
2011 Virology Identiﬁcation
of novel eel
virus
Supernantant
from infected
JEE culture
cells
– – – – – GenomePlex
Whole
Genome
Ampliﬁcation
or GenomiPhi
(GE
Healthcare)
Sanger-
method or
454FLX
sequencing
(Roche)
Broad surveys of
DNA viral
diversity
obtained
through viral
metagenomics
of mosquitoes
Ng et al. 2011 PLOS ONE Viral diversity
study in
mosquito
Whole
mosquito
homogenate
– GenomiPhi
(GE
Healthcare)
454 GS20 and
454FLX
sequencing
(Roche)
Exploring the
diversity of
plant DNA
viruses and their
satellites using
vector-enabled
metagenomics
on whiteﬂies
Ng et al. 2011 PLOS ONE To investigate
the diversity
of DNA
viruses in
whiteﬂies
collected
from different
crops in 2
agriculturally
important
sites in
Florida using
vector-
enabled
metage-
nomics
(VEM).
Whiteﬂy
homogenate
– Genomiphi
(GE
Healthcare)
and
GenomePlex
(Sigma–Aldrich)
Cloning and
sanger-
method
Random PCR and
ultracentrifuga-
tion increases
sensitivity and
throughput of
VIDISCA for
screening of
pathogens in
clinical
specimens
Tan et al. 2011 Journal of
Infection in
Developing
Countries
Screening for
unknown
pathogens in
clinical
specimens
Clinical
samples of
plasma,
throat swab,
nasal
pharyngeal
aspirate.
– – – – VIDISCA cDNA-AFLP,
cloning and
sanger-
method
Metagenomic
analysis of fever,
thrombocyto-
penia and
leukopenia
syndrome (FTLS)
in Henan
Province, China:
Discovery of a
new bunyavirus
Xu et al. 2011 PLOS
Pathogens
Discovery of a
new
bunyavirus in
cases of fever,
thrombocyto-
penia and
leukopenia
syndrome
(FTLS)
Supernatant
from infected
Vero cell
culture
– – – – Sequence-
Independent
Ampliﬁcation
Cloning and
sanger-
method
R
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Simultaneous
identiﬁca-
tion of DNA
and RNA
viruses
present in
pig faeces
using
process-
controlled
deep
sequencing
Sachsenröder
et al.
2012 PLOS ONE To establish a
protocol for
the
simultaneous
analysis of
DNA and RNA
viruses
present in pig
faeces
Faecal
suspension
Transplex
(WTA2,
Sigma–Aldrich)
454FLX
sequencing
(Roche)
Sequence-
independent
VIDISCA-
454
technique
to discover
new viruses
in canine
livers
van der
Heijden
et al.
2012 Journal of
Virological
Methods
Test the
feasibility of
VIDISCA-454
to obtain viral
sequence
information
from
idiopathic
canine
hepatitis liver
biopsy.
Canine BDE
cell culture
supernatant
– – – – – VIDISCA 454FLX
sequencing
(Roche)
Identiﬁcation
of a novel
bat papillo-
mavirus by
metage-
nomics
Tse et al. 2012 PLOS ONE Discovery and
characterisa-
tion of a novel
bat papillo-
mavirus from
rectal swabs
of asymp-
tomatic wild,
food and pet
animals using
metage-
nomics
Animal rectal
swabs
– – – – Rapisome
pWGA
(Biohelix)
454 GS FLX
sequencing
(Roche)
Complete
genome
sequence of
an
astrovirus
identiﬁed in
a domestic
rabbit
(Oryctola-
gus
cuniculus)
with gas-
troenteritis
Stenglein
et al.
2012 Virology
Journal
To screen
samples from
a gastroen-
teritis
outbreak in a
commercial
rabbit colony
Faecal
suspension
– – – – PCR Cloning and
sanger-
method
Publications referred to include: Allander et al. (2001), Breitbart et al. (2003), Daly et al. (2011), Djikeng et al. (2008), Isawa et al. (2011), Kapoor et al. (2008), Mizutani et al. (2011), Ng et al. (2011a), Ng et al. (2009), Ng et al.
(2011b), Sachsenroder et al. (2012), Smits et al. (2010), Svraka et al. (2010), Tan le et al. (2011), Thurber et al. (2009), van der Hoek et al. (2004), van Leeuwen et al. (2010), Victoria et al. (2008), Xu et al. (2011).
Low-speed centrifugation.
Filtration (excludes tangential ﬂow).
Ultracentrifugation.
Nuclease treatment.
Unclassiﬁed method.
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Fig. 1. Amountofmodel organismsdetectedusingquantitative real-timePCR,when
different virus enrichment methods are applied. Amounts are measured as copy
numberof a targetgene, representedas log10 values. Theaverageof two independent
replicates are shown, with two PCR tests performed per replicate. Error bars showMethods 195 (2014) 194–204
step at 95 ◦C, a 2-step cycling procedure of denaturation at 95 ◦C for
15 s with annealing and extension at 55 ◦C for 1min over 45 cycles
was used.
Enterovirus RNA was detected using a previously described
assay (Oberste et al., 2010) and the SuperScript III Platinum One-
Step System (Life Technologies, Carlsbad, CA, USA). Each 25L
reaction contained 5L of RNA, 12.5L of 2X Invitrogen Reac-
tion Mix, 0.5L of 50mM MgSO4, 0.5L of SuperScript® III
RT/Platinum® Taq Mix, 0.1M probe and 0.4M primers. Follow-
ing an initial 30min reverse transcription step at 50 ◦C and 2min
denaturation step at 95 ◦C, a 3-step cycling procedure of denatur-
ation at 95 ◦C for 15 s, annealing at 55 ◦C for 45 s and extension at
72 ◦C for 10 s over 45 cycles was used.
For E. coli O157 a one-step assay was performed using the
LightCycler® 480 Probes Mastermix (Roche, Indianapolis, IN, USA)
as previously described (Paton and Paton, 1998; Thomas et al.,
2012). Each 20L reaction contained 2L of DNA, 10L of
LightCycler® 480 Probes Master, 0.2M probe (stx1) and 0.5M
primers (O0218 and O0220). Following an activation step of 95 ◦C
for 2min, a 3-step cycling procedure of denaturation at 95 ◦C for
10 s, annealing at 54 ◦C for 15 s and extension at 72 ◦C for 15 s over
45 cycles was used.
Every assay included negative and positive controls, and
RNase-free reagents and handling procedures. The real-time PCR
assays were made quantitative by including a dilution series of
a plasmid with known copy number, which contained concate-
nated primer–probe–primer target sequences for each of the ﬁve
assays.
2.5. Metagenomic sequencing
DNA was co-puriﬁed with RNA during the nucleic acid extrac-
tion method, and thus DNA was removed using Ambion DNA-free
(Life Technologies, Carlsbad, CA, USA), then 8L of this RNA was
reverse transcribed into cDNA using a ﬁrst-strand cDNA synthe-
sis kit primed by random hexamers as per the manufacturer’s
instructions (Life Technologies, Carlsbad, CA, USA) including the
recommended RNase H digestion. The minimum 1g amount of
DNA required for input into the Illumina TruSeqDNA library prepa-
ration protocol was not achieved. Ampliﬁcation of the cDNA was
achieved by using a Whole Transcriptome Ampliﬁcation kit (Qia-
gen, Valencia, CA, USA) as described previously (Berthet et al.,
2008; Cheval et al., 2011). Brieﬂy, the reverse transcription step
required in the kit was not utilised, but the ligation and ampliﬁ-
cation steps were followed as per the manufacturer’s instructions
except that the ligation reactionwas terminated by heating to 95 ◦C
for5min, and theampliﬁcation stepwasperformed for2h followed
by termination of the reaction at 65 ◦C for 3min. For each sample
more than 1g of DNA was produced and this was sequenced on
an Illumina MiSeq instrument (New Zealand Genomics Limited,
Massey Genome Service, Massey University, Palmerston North,
New Zealand) using an Illumina TruSeq DNA library preparation
(Illumina, San Diego, CA, USA). Water-only negative controls failed
to amplify any DNA.
3. Bioinformatic analysisIllumina MiSeq sequence data consisted of 150bp paired-end
reads. Quality checking and redundant-read collapsing was per-
formed and sequence reads were then compared to the NCBI
non-redundant nucleotide database (downloaded from NCBI FTP
the 95% conﬁdence interval. The grey line represents the copy number of the target
gene when no enrichment method is applied.
ogical Methods 195 (2014) 194–204 201
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ite in February 2013) using BLASTN (BLAST+ 2.26). An E value of
.0001 was used as the cut-off threshold value for signiﬁcant hits.
he BLASTN output ﬁles were imported and parsed in MEGAN 4
Huson et al., 2011) for taxonomic assignment.
. Results
.1. Abundance of RNA targets as measured by quantitative
eal-time PCR detection
The abundance of nucleic acid from the model organisms in the
rtiﬁcial sample (human cells, bacteria, inﬂuenza, adenovirus and
nterovirus) was determined by using quantitative real-time PCR.
he effect of different enrichment methods on target gene copy
umber was assessed (Fig. 1). In general, all enrichment methods
ecreased thequantity of everymodel organismwhen compared to
o treatment at all. HumanRNAwas removed to a limited extent by
ll themethods,with the3-step treatment andnuclease-only treat-
ents being the most effective, resulting up to 100-fold reduction
n copynumber. Similarly, somebacterial nucleic acidwas removed
y all of the enrichment methods, with the nuclease-only or the
-step treatment being the most effective.
The three viruses used in this experiment represent a DNA
irus (adenovirus), and two RNA viruses one of which is enveloped
inﬂuenza) and the other non-enveloped (enterovirus). The subse-
uent metagenomic analysis was targeted at the detection of RNA
iruses, but a DNA virus was included to assess the potential to
etect DNA viruses using this methodology. Each virus also repre-
ented a different level of concentration (1) a high concentration
t 2×106 copies (enterovirus), (2) a moderate concentration (ade-
ovirus) at 50,000 copies and (3) a low concentration (inﬂuenza) at
,000 copies. All viruses showed a decrease in copy number when
n enrichment method was applied. This decrease was consistent
cross all enrichment methods, with most showing no greater than
10-fold reduction in copynumber except the3-stepmethodwhen
pplied to enterovirus, where the virus copy number was reduced
y 100-fold.
.2. Relative abundance of organisms in the metagenomic dataset
The same RNA extraction that was used for the qPCR was also
sed for a metagenomics experiment (Fig. 2 and Table 2). The ﬁrst
eplicate sampleof each treatmentwas indexedand runonone Illu-
ina MiSeq run producing 5,913,177 sequence reads of 150bp in
ength, the second replicate setwas indexedand runonan indepen-
ent IlluminaMiSeq run and produced 12,664,374 sequences reads
f 150bp in length.After submission toBLASTN, each sequence read
as given a taxonomic assignment using MEGAN.
All ﬁve model organisms were represented in the untreated
amples (Fig. 2andTable2) and for simplicityofdata representation
he family level of Enterobacteriaceae was chosen to represent the
.coli organism in the sample, which was the most abundant taxa
dentiﬁed accounting for 76.9% of the total sequences (1,523,514
eads; Table 2). The kingdom level of Metazoa was chosen to repre-
ent thehumancellswithin theuntreated sample,whichaccounted
or 2% of the total reads (39,481 reads; Table 2). The decision to
se Metazoa and Enterobacteriaceae was made to facilitate sim-
le representation of the data, but was arbitrary, as the aim of
his experiment was to compare variations in the proportions of
acteria, human cells and viruses between the enrichment meth-
ds. Viruses were present in the untreated sample in the following
roportions; enterovirus 0.2% (3,221 reads), adenovirus 0.002% (40
eads) and inﬂuenza virus 0.001% (20 reads). It is interesting that
he DNA virus, adenovirus, was identiﬁed in the dataset, given that
he method was targeted at RNA viruses. The remainder of reads
Fig. 2. Relative abundance of taxonomically assigned sequence reads in the viral
metagenomic sequence dataset, shown for different enrichment methods. Average
values are shown for two independent replicates, and error bars represent the 95%
conﬁdence interval.
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Table 2
Quantity and proportion of sequence reads with a positive BLASTN hit against the model organism groups used in the virus discovery metagenomic dataset, comparing the
effect of different virus enrichment methods.
Treatment Total number of
sequence readsa
Metazoa Enterobacteriaceae Adenovirus Inﬂuenza Enterovirus
BLASTN hits % total BLASTN hits % total BLASTN hits % total BLASTN hits % total BLASTN hits % total
No treatment 1,980,878 39,481 1.99% 1,523,514 76.9% 40 0.002% 20 0.001% 3,221 0.16%
Centrifuge 2,010,717 48,719 2.42% 1,486,125 73.9% 0 0.000% 77 0.004% 14,805 0.74%
Filtration 1,941,626 65,746 3.39% 1,334,433 68.7% 6 0.000% 110 0.006% 22,731 1.17%
Nuclease 1,821,828 5,148 0.28% 1,421,268 78.0% 17 0.001% 14 0.001% 2,532 0.14%
2-step treatmentb 1,730,569 53,421 3.09% 1,199,232 69.3% 14 0.001% 57 0.003% 18,712 1.08%
3-step treatmentb 1,417,803 26,856 1.89% 857,873 60.5% 16 0.001% 161 0.011% 67,227 4.74%
a Combined total number of sequence reads for two independent physical replicates which were also run on different Illumina MiSeq ﬂowcells. This ﬁgure represents the
collapsed sequencing data, therefore redundant reads are not represented more than once.
b Serial applications of treatment methods. The 2-step method consisted of centrifugation then ﬁltration. The 3-step method consisted of centrifugation, ﬁltration then
n
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21.1%) that were not assigned to these aforementioned taxa were
ccounted for as either (1) no hit in the blast search, (2) no clear
axonomic assignment from the blast search due to the stringency
f parameters required by MEGAN for taxonomic assignment (3)
ow complexity sequence (4) assignment to a taxonomic level that
as not captured by Enterobacteriaceae, Metazoa or viruses.
The enrichment techniques did not greatly change the relative
bundance of Enterobacteriaceae, at best there was a 15% reduction
n the number of reads assigned to this taxon when applying the
-step treatment. There was an increase in the proportion of Meta-
oa sequences when ﬁltration was applied increasing from 2% to
.3%, with only the nuclease-treatment showing the greatest effect
educing Metazoan sequence to 0.3% (a 6-fold reduction).
Forviruses, the3-step treatmentwas theonly treatment to show
signiﬁcant increase in the proportion of viral sequence, by 10-fold
or inﬂuenza (from0.001% to0.01%)and20-fold for enterovirus. The
roportion of adenovirus hits appeared unaffected by all enrich-
ent methods (Fig. 2).
. Discussion
This study compares the effect of ﬁve different viral enrich-
ent methods on the ability to detect viruses in a metagenomic
pproach. Enrichment techniques were deliberately chosen that
ave been commonly referenced in previous metagenomic studies
hich seek to identify new or rare viruses (Table 1). These enrich-
ent methods are often selected without prior justiﬁcation. The
ffect of these enrichment techniqueswas examinedby application
o a highly speciﬁc artiﬁcial sample. This study does not provide a
ull validation of the enrichmentmethods, but highlights somepos-
ible risks if an enrichment method is selected based solely upon
ethods published by others and without consideration for the
ample being examined.
Validation of enrichment techniques in the ﬁeld of virus ecology
s well developed (Duhaime and Sullivan, 2012; John et al., 2011),
ut there is a paucity of data on the validation of enrichment meth-
ds applied to the detection of viruses in animal or human samples
or the purpose of diagnosis. In the present study, an artiﬁcial sam-
le was composed which represents the type of organisms that
ould possibly be observed in clinical samples i.e. a rectal swab
aken from a human patient. Of course, the artiﬁcial sample is
nlikely to have similar characteristics to complex biological sam-
les from humans or animals. Bacteria are often a very abundant
rganism in de novo metagenomic datasets, and host sequence is
lso oftenpresent. To this end,E.coli andahumancell linewere cho-
en, as well as two RNA viruses (inﬂuenza virus, enterovirus) and a
NA virus (adenovirus). The DNA virus was included to assess the
otential for detectionwhenusing an RNAvirus targeted approach,as many virus discovery projects have to create two workﬂows to
independently target DNA or RNA viruses. Differing amounts of
each virus were placed into the artiﬁcial sample so as to represent
varying concentrations. This artiﬁcial sample represents a starting
point to evaluate simple and rapid viral enrichment methods for
use in virus metagenomics studies that seek to detect a virus that
is causing disease in humans or animals. At present, there is little
guidance for researchers seeking towork in this area and published
studies have often selected these simple enrichment techniques
with no justiﬁcation for their inclusion in the method.
Ingeneral, itwasobserved that thechoiceof enrichmentmethod
such as low speed centrifugation, syringe-based ﬁltration, nuclease
treatment (DNase and RNase) or combinations of these methods,
did not substantially increase the relative abundance of viruses in
thismetagenomics dataset, except in selected cases. Despite reduc-
tions in the quantity (copy number) of bacterial and human RNA
gene targets as shown in the qPCR data, this did not translate into
a substantially increased relative abundance for viral sequences
in the metagenomic data. The qPCR method detects the absolute
quantity of genome target present, whereas the metagenomic data
is proportional (relative abundance). Even though large gains can
be made in reducing bacteria and human nucleic acid, the propor-
tion of viral sequences in the metagenomic datasets still remained
relatively low (i.e. generally less than 1%) except for when a 3-step
enrichment method was applied. Nevertheless, individual enrich-
ment methods did have some effect on relative abundance of the
model organisms’ representation in themetagenomics data. Nucle-
ase treatment alone was successful in reducing the proportion of
human (Metazoa) sequences by 10-fold. It is hypothesised that the
initial freeze–thaw processing of the artiﬁcial sample has lysed
human cells and thus liberated human genome. This exogenous
nucleic acid is more susceptible to digestion by nuclease than the
protected bacterial and viral genomes, which are protected by
membranes or capsids, which are more resistant to freeze–thaw
action.
The 3-step treatment was particularly effective at increasing
the abundance of both inﬂuenza and enterovirus, both in abso-
lute concentration as measured by real-time PCR, and also relative
abundance as measured in the metagenomics data. This ﬁnding
supports the use of the 3-step procedure for virus enrichment,
and similar 3-step procedures have previously been employed in
published virus metagenomic studies (Table 1).
Regarding sensitivity, without an enrichment method 5×103
copies of inﬂuenza virus genome were detected using a metage-
nomic approach (20 sequence reads; Table 2), and the detection of
the DNA genome of adenovirus present at 10×104 copies (3221
sequence reads; Table 2) was also possible. This experiment was
targeted at the discovery of RNA viruses but included theDNA virus
ogical
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adenovirus) to determine if an RNA virus detection method could
lso co-detect DNA viruses. Given that the starting material used
or this experiment is RNA, it is possible to surmise that adenovirus
RNA expressed during infectionwas detected. However, thismay
ot be the correct explanation as the DNAse treatment used before
DNA synthesis is known to be less than 100% efﬁcient, and some
NA is likely to have been carried right through into the sequencing
ibrary preparation. The ability to detect DNA viruses when using
n RNA-targeted method will also no doubt be inﬂuenced by the
peciﬁc replication cycle of any given virus.
It is noted that the viral metagenomic method chosen uses mul-
iple displacement ampliﬁcation, and therefore there is likely to
e a bias in the ampliﬁcation of larger genomes e.g. bacteria and
ost, which could confound results when considering the relative
bundance of sequences in the metagenomic data. There are many
ifferent methods of ampliﬁcation that are available and this rep-
esents only one. However, this ampliﬁcation method is one that is
n practical use, and has been applied in other virus discovery stud-
es (Cheval et al., 2011), therefore the examination of enrichment
echniques using this speciﬁc ampliﬁcation method are still rele-
ant. There is a certainly a need for future studies to expand this
ork into a full validation, so as to examine the effect of enrich-
ent when using other ampliﬁcation methods i.e. SISPA, nextera,
AMP, LASL. It would also be interesting to include a greater array
f enrichment methods, sample types, sequencing platforms and
ioinformatics approaches which may include the incorporation
f sequence assembly methods, or the use of other search algo-
ithms. The ﬁndings presented here should provide a starting point
or those considering the use of rapid or simple enrichment meth-
ds for the purposes of diagnosing new viral diseases in human or
nimal samples by using metagenomics. This study also highlights
he possible risks of arbitrarily selecting an enrichment method
urely based upon previously published studies.
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